FDA
-
-
-
-
-
-
-
Actinogen announces further positive results on depression in the XanCIDD phase 2a trial
-
-
-
-
-
-
-
Actinogen to present progress on Phase 2 trials at the BIO Investor Forum, San Francisco and Clinical Trials on Alzheimer's Disease (CTAD) Conference, Boston
-
-
-
-
-
-
322,246 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

